Skip to content

Intraoperative endoscopic retrograde sphincterotomy as a modality of treatment of choledocholithiasis

Intraoperative endoscopic retrograde sphincterotomy as a modality of treatment of choledocholithiasis

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
RPCEC
Registry ID
RPCEC00000013
Enrollment
Unknown
Registered
2008-11-14
Start date
2007-11-06
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

choledocholithiasis

Interventions

A prospective randomized controlled clinical trial compared three management options for the patients with choledocholithiasis. In summary, the intake was restricted to fit patients (ASA I and II) in
Sphincterotomy, Endoscopic
Cholecystectomy, Laparoscopic
Cholangiopancreatography, Endoscopic Retrograde

Sponsors

National Center for Minimal Access Surgery
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients older than 15 years-old, both gender, with gallbladder in situ and preoperative suspect of choledocholithiasis CLINICAL FEATURES: Jaundice – Recent acute pancreatitis or cholangitis – Colic pain with jaundice and pyrexia LIVER FUNCTION TESTS: Elevated bilirubin, alkaline phosphatase and GGT EXTERNAL ULTRASOUND FINDINGS Common bile duct > 8 mm- Common bile duct Stone

Exclusion criteria

Exclusion criteria: - Acute cholecystitis – Acute cholangitis – Acute pancreatitis - Contraindication for laparoscopic surgery and/or ERCP – Anesthetic contraindication ( ASA IV y V)- Pregnant woman- ERCP previous- Extensive adhesions in abdominal right quadrant- Patients that refuse the treatment

Design outcomes

Primary

MeasureTime frame
"Success on the procedures of stone extraction", timepoint: at the end of surgical procedure. "Morbidity and mortality", timepoint: at the follow-up, on 30 days after procedure.

Secondary

MeasureTime frame
"Operative time”, timepoint: at the end of surgical procedure. "Hospital stay", timepoint: at the follow-up, on 1-7 days after procedure. "Diagnosis of residual choledocholithiasis", timepoint: at the follow-up, on 2 years after procedure. "Cost of surgical procedure”, timepoint: at the end of hospital stay.

Countries

Cuba

Contacts

Public ContactJavier Barreras González

National Center for Minimal Access Surgery

javier@cce.sld.cu

Outcome results

None listed

Source: RPCEC (via WHO ICTRP) · Data processed: Aug 15, 2026